Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Esperion Theraptc (ESPR)

Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Esperion Theraptc 3891 RANCHERO DRIVE SUITE 150 ANN ARBOR MI 48108 USA

www.esperion.com P: 734-887-3903

Description:

Esperion Therapeutics, Inc. is a pharmaceutical company focused on the development of oral lipid-management treatments for cardiovascular diseases caused by elevated levels of LDL-C (bad cholesterol).

Key Statistics

Overview:

Market Capitalization, $K 403,424
Enterprise Value, $K 321,174
Shares Outstanding, K 189,401
Annual Sales, $ 116,330 K
Annual Net Income, $ -209,250 K
Last Quarter Sales, $ 32,250 K
Last Quarter Net Income, $ -56,340 K
EBIT, $ -155,570 K
EBITDA, $ -154,120 K
60-Month Beta 0.84
% of Insider Shareholders 1.00%
% of Institutional Shareholders 47.39%
Float, K 187,507
% Float 99.00%
Short Volume Ratio 0.58

Growth:

1-Year Return 65.83%
3-Year Return -92.10%
5-Year Return -95.07%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 73.08%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.50 on 02/27/24
Latest Earnings Date 05/07/24
Earnings Per Share ttm -2.12
EPS Growth vs. Prev Qtr -35.14%
EPS Growth vs. Prev Year 34.21%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ESPR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -91.62%
Profit Margin % -179.88%
Debt/Equity 0.00
Price/Sales 3.40
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -3.85
Interest Coverage -2.55
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar